Actinium Pharmaceuticals Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.26

-0.02 (-1.56%)

As of May 16, 2:23 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 82%

Hold 2 18%

Sell 0 0%

Price Target

Analyst Price Target +2,765.9% upside

Low Target $23.47

Average Target $36.11

High Target $39.96

Current Price $1.26

Current
$1.26

Target
$36.11

$23.47 $36.11 avg $39.96

Scenario Analysis

Bear Case

$23.47

1,762.7%

Low target

Base Case

$36.11

+2,765.9%

Avg target

Bull Case

$39.96

+3,071.4%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$1.95

-35.2% from high

52-Week Low

$0.95

+32.4% from low

Target vs 52W High

$36.11

+1,756.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%